Ari Weiser
Strategic Finance Director @Ultima Genomics
Signup · Get unlimited contacts
WORK HISTORY
Strategic Finance Director @Ultima Genomics
San Francisco, CA, US
Investor Strategy: Lead end-to-end development of corporate strategy presentation, synthesizing market research and robust analytics into cohesive narrative for executive leadership and external stakeholders; scope includes market sizing, customer segmentation, competitive positioning, commercial performance, and long-term value creation• Deal Economics: Structured enterprise proposals for key clinical customers, incorporating assay-driven utilization and CapEx modeling, total workflow cost of ownership, and reimbursement / margin dynamics• Financial Leadership: Designed and manage the company’s integrated 3-statement corporate financial model to inform long-range planning, capital allocation, scenario analysis, and Board of Director materials• Commercial Assessment: Led comprehensive revenue analysis for strategic growth opportunity by evaluating customer contracts and retention trends, providing actionable insights for executive decision-making
EDUCATION
The Wharton School
Master of Business Administration (M.B.A.), Finance
University of Pennsylvania
Master of Science in Education (M.S.Ed.), Secondary Science
University of Chicago
Bachelor of Arts (B.A.) with Honors
SKILLS
ABOUT ARI WEISER
Life sciences corporate development and strategic finance professional focused on tools and diagnostics with experience across operating companies, management consulting, and corporate finance. Energized by shaping and executing enterprise growth through rigorous financial analysis and market judgment to drive real-world patient impact.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.